Chanos says he's still short Valeant (VRX), started in low $100s - CNBC

September 13, 2016 12:46 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Short-seller Jim Chanos says he's still short Valeant Pharma (NYSE: VRX) and started in the low $100s, according to commentary on CNBC.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Short Sales, Trader Talk

Related Entities

Jim Chanos

Add Your Comment